Immunome is a biopharmaceutical company that utilizes its proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics that are designed to change the way diseases are treated.

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

immunome.com →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Geely: Positive On Profit Surge And Favorable Prospects

KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Paysafe Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PSFE

BellRing Brands, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BRBR

Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Kα Inhibitor Program

Tripadvisor: Activist Pressure Supports Our Upside Outlook

Standard Chartered, BSI lose bid to join cases in Singapore winding up firms with assets linked to 1MDB

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

WELL Health Technologies Corp. (WELL:CA) Q4 2025 Earnings Call Transcript

1 Dividend ETF That Could Turn $500 Monthly Into a $725,000 Portfolio That Pays $21,750 Annually

Japan may stockpile US oil domestically, PM says

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

Oil Falls, Asian Equities Mixed Amid Easing Supply-Disruption Concerns

What to Know About Tesla's Terafab Project and the Company's AI Future

Could Investing $10,000 in VONG Make You a Millionaire?

Tantalus Systems Holding Inc. (GRID:CA) Q4 2025 Earnings Call Transcript

LetPot Achieves Amazon Best Seller Status Across Multiple Markets in 2025 Holiday Season

TITAN S A (TTCIF) Q4 2025 Earnings Call Transcript

Forerunner Ventures Builds $227 Million Position in Chime Financial, According to Recent SEC Filing

About